These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8537670)

  • 1. Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes.
    Dentener MA; Francot GJ; Buurman WA
    J Infect Dis; 1996 Jan; 173(1):252-5. PubMed ID: 8537670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two monoclonal antibodies directed against bactericidal/permeability-increasing protein.
    Dentener MA; Smit FT; Francot GJ; Buurman WA
    J Infect Dis; 1994 Dec; 170(6):1483-9. PubMed ID: 7995988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J
    J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes.
    Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP
    J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.
    Qi SY; Li Y; O'Connor CD
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):711-8. PubMed ID: 8141787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J; Muello K; Victor M; Elsbach P
    J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
    Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
    Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mononuclear cell line THP-1 internalizes bactericidal/permeability-increasing protein by a non-receptor-mediated mechanism consistent with pinocytosis.
    Burnett RJ; Lyden CA; Tindal CJ; Cave CM; Marra MN; Solomkin JS
    Arch Surg; 1996 Feb; 131(2):200-5; discussion 206. PubMed ID: 8611079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
    J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P; Weiss J
    Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
    Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.
    Marra MN; Thornton MB; Snable JL; Leong S; Lane J; Wilde CG; Scott RW
    Blood Purif; 1993; 11(2):134-40. PubMed ID: 7506040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.
    Arditi M; Zhou J; Huang SH; Luckett PM; Marra MN; Kim KS
    Infect Immun; 1994 Sep; 62(9):3930-6. PubMed ID: 8063410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures.
    Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL
    Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural and immunocytochemical study of the uptake and distribution of bacterial lipopolysaccharide in human monocytes.
    Kang YH; Dwivedi RS; Lee CH
    J Leukoc Biol; 1990 Oct; 48(4):316-32. PubMed ID: 2118560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE; Weiss J; Doerfler ME; Elsbach P
    J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS.
    Tobias PS; Soldau K; Iovine NM; Elsbach P; Weiss J
    J Biol Chem; 1997 Jul; 272(30):18682-5. PubMed ID: 9228038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
    Mannion BA; Kalatzis ES; Weiss J; Elsbach P
    J Immunol; 1989 Apr; 142(8):2807-12. PubMed ID: 2539411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
    J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW
    J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.